Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
The Journal of Urology
|
February 25, 1998
p53 status does not predict initial clinical response to bacillus Calmette-Guerin intravesical therapy in T1 bladder tumors
F Pages, T A Flam, A Vieillefond, et al.
American Journal of Human Genetics
|
June 28, 2000
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families
P Ciotti, J P Struewing, M Mantelli, et al.
British Journal of Cancer
|
August 1, 1996
Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts
G Vassal, M J Terrier-Lacombe, M C Bissery, et al.
Journal of Medical Genetics
|
May 31, 2008
Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families
G Bougeard, R Sesboüé, S Baert-Desurmont, et al.
Cancer Research
|
May 1, 1998
Mutations at BRCA1: the medullary breast carcinoma revisited
F Eisinger, J Jacquemier, C Charpin, et al.
British Journal of Cancer
|
March 25, 2000
Extensive molecular screening for hereditary non-polyposis colorectal cancer
B Dieumegard, S Grandjouan, J C Sabourin, et al.
Familial Cancer
|
September 16, 2010
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma
B Buecher, M Gauthier-Villars, L Desjardins, et al.
Genes, Chromosomes & Cancer
|
October 2, 2001
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect
S Auroy, M F Avril, A Chompret, et al.
The Journal of Endocrinology
|
August 9, 2003
Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours
V V Vax, R Bibi, S Diaz-Cano, et al.
Human Mutation
|
June 1, 2001
The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript
A Vega, B Campos, B Bressac-De-Paillerets, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
The Journal of Urology
|
February 25, 1998
p53 status does not predict initial clinical response to bacillus Calmette-Guerin intravesical therapy in T1 bladder tumors
F Pages, T A Flam, A Vieillefond, et al.
American Journal of Human Genetics
|
June 28, 2000
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families
P Ciotti, J P Struewing, M Mantelli, et al.
British Journal of Cancer
|
August 1, 1996
Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts
G Vassal, M J Terrier-Lacombe, M C Bissery, et al.
Journal of Medical Genetics
|
May 31, 2008
Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families
G Bougeard, R Sesboüé, S Baert-Desurmont, et al.
Cancer Research
|
May 1, 1998
Mutations at BRCA1: the medullary breast carcinoma revisited
F Eisinger, J Jacquemier, C Charpin, et al.
British Journal of Cancer
|
March 25, 2000
Extensive molecular screening for hereditary non-polyposis colorectal cancer
B Dieumegard, S Grandjouan, J C Sabourin, et al.
Familial Cancer
|
September 16, 2010
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma
B Buecher, M Gauthier-Villars, L Desjardins, et al.
Genes, Chromosomes & Cancer
|
October 2, 2001
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect
S Auroy, M F Avril, A Chompret, et al.
The Journal of Endocrinology
|
August 9, 2003
Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours
V V Vax, R Bibi, S Diaz-Cano, et al.
Human Mutation
|
June 1, 2001
The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript
A Vega, B Campos, B Bressac-De-Paillerets, et al.
Page
of 7